Moreover, a previous study reports that YAP1’s transcriptional activity is modulated by oncogenic KRAS signaling through the MAPK pathway in pancreatic ductal adenocarcinoma without changing its subcellular location. This evidence concerns the gene YAP1 and pancreatic ductal adenocarcinoma.